Health & Environmental Research Online (HERO)


Print Feedback Export to File
7040518 
Journal Article 
Efficacy and safety of a fixed-dose combination of D-norpseudoephedrine, triiodothyronine, atropine, aloin, and diazepam in obese patients 
Del Valle-Laisequilla, CF; Trejo-Jasso, C; Huerta-Cruz, JC; Barranco-Garduño, LM; Rodríguez-Silverio, J; Rocha-González, HI; Reyes-García, JG; , 
2018 
Yes 
International Journal of Clinical Pharmacology and Therapeutics
ISSN: 0946-1965 
DUSTRI-VERLAG DR KARL FEISTLE 
DEISENHOFEN-MUENCHEN 
531-538 
English 
30148450 
WOS:000448033700004 
A fixed-dose combination (FDC) of D-norpseudoephedrine, tri-iodothyronine, atropine, aloin, and diazepam is used in Mexico for the short-term treatment of obesity; however, its efficacy and safety have been scarcely studied. The aim of this study was to analyze the efficacy and safety of this FDC in Mexican adult overweight and obese patients by a prospective, uncontrolled, multicenter, phase IV open-label study. 
• PFAS Universe
     Data Source
          Web of Science
     Perflunafene